PMU47 ORPHAN DRUG DESIGNATION: NO IMPACT ON P&R PROCESS...

Value in Health 2019 / 11 Vol. 22

PMU47 ORPHAN DRUG DESIGNATION: NO IMPACT ON P&R PROCESS TIMING IN ITALY

Enrici, A., Lidonnici, D., Isernia, M., Lanati, E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.1666
Date:
November, 2019
File:
PDF, 368 KB
2019
Conversion to is in progress
Conversion to is failed